Back to search page

TRKR20181107001

Virtual screening technology based on deep learning using big data

TECHNOLOGY PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A Korean pharmaceutical company is active in research and development of new drugs based on natural products and orphan disease through virtual screening technology on the basis of AI. The technology that the company wants to develop by cooperation is virtual screening technology based on deep learning using big data. The type of partnership is commercial agreement with technical assistance.


FULL DESCRIPTION

A Korean company is a pharmaceutical-based and established in 2018.

The company specializes in development of new drugs of orphan diseases with a use of virtual screening technology. The company comes up with the idea of the new drugs based on natural products due to treatment of orphan diseases and senile diseases in a short period of time, which result in high quality of life eventually.

The company is planning on development of new drugs with improved functions that would enable to be applied on orphan disease and general diseases with partners under commercial agreement with technical assistant.


Partner expertise sought:

- Type of partner sought: Reducing the time of development of new drugs as well as reducing the risk of failure result in costs for research and development ultimately. As technology is a competitive advantage, it will lead the world pharmaceutical market. Also, pharmaceutical and bio-pharma and engineering technology based on IT software are fused to create new values, which could provide new industries and jobs eventually.
- Specific area of activity of the partner: - Type of partner: Technological SME or large enterprise is preferable with experience in Big data(AI)

- Specific area of activity of the partner: Any partner specialized in the technology for screening technology based on deep learning using big data

- Task to be performed: Partners should engage in pharmaceutical companies or research institute or specialize in virtual screening technology in the basis of deep-learning to develop new drugs on orphan disease under commercial agreement with technical assistance.


Development Stage:

Available for demonstration

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
SOUTH KOREA
Profile date
09/01/2019
Deadline
10/01/2020

PARTNERSHIP(S) SOUGHT

Commercial agreement with technical assistance

CLASSIFICATIONS

INDUSTRY SECTORS
Communications & Networking \ Building and Construction \ Software \ Internet and Wireless Technologies (Wireless, WiFi, Bluetooth) \ TechUK Single Mapping, August 2014
TECHNOLOGY KEYWORDS
ELECTRONICS, IT AND TELECOMMS / Information Processing & Systems, Workflow / Artificial Intelligence (AI) / ELECTRONICS, IT AND TELECOMMS / Information Processing & Systems, Workflow / Data Processing / Data Interchange, Middleware / ELECTRONICS, IT AND TELECOMMS / Information Processing & Systems, Workflow / Data Protection, Storage, Cryptography, Security / ELECTRONICS, IT AND TELECOMMS / Information Processing & Systems, Workflow / Databases, Database Management, Data Mining
COMMERCIAL KEYWORDS
none...
MARKET KEYWORDS
COMMUNICATIONS / Data Communications / Data communication components / COMPUTER RELATED / Computer Services / Data processing, analysis and input services / COMPUTER RELATED / Computer Services / Big data management / COMPUTER RELATED / Computer Software / Database and file management / COMPUTER RELATED / Computer Software / Artificial intelligence programming aids

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number TRKR20181107001